By elucidating the shared signaling cascades and molecular mechanisms affecting breast cancer proliferation and metastasis in diabetic states, potential therapeutic avenues targeting FAK and ROCK for the management of these pathologies can be determined. This evidence concerns the gene PTK2 and breast cancer.